JP: We're getting down to crunch time. It is time to deliver. If we are to up list in December without a massive RS, then the pps must rise due to some kind of LymPro partnership. It is possible that the spin off might happen before the partnership. You bring up all the pertinent issues. Gerald has left it nebulous.
But the clock is ticking. I doubt Gerald would have announced publicly his bonus being tied to the up list unless he had his ducks in a row. He doesn't want to set himself up for a public defeat. So I imagine the nebulous clouds will soon blow away and the sun will start shining.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links